J. Nick Riehle, Chief Financial Officer at Chelsea Therapeutics International, Ltd. (CHTP), bought 46,020 shares at $3.20 ($9K) on 2008-09-25, disclosed to the SEC on 2008-09-25.
Open-market purchase of $9k CHTP by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.07 | 44,020 | $3K | 32.6% |
| 2 | $3.12 | 500 | $2K | 16.5% |
| 3 | $3.20 | 500 | $2K | 16.9% |
| 4 | $3.20 | 1,000 | $3K | 33.9% |
| Total | $0.21 avg | 46,020 | $9K | 100% |
| Filing → |
| CHTP | BUY | 2009-12-22 | $6K | — | Filing → |